CORNELIA PASQUINI: Open Payments
NPI 1932160579 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 45 payments from 13 companies in 2025. Trend: 2023 $1,401 · 2024 $1,433 · 2025 $1,109
Food & beverage: $1,109
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $184 |
| Alnylam Pharmaceuticals Inc. | 4 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $139 |
| SCPHARMACEUTICALS INC. | 1 | $122 |
| BridgeBio Pharma, Inc. | 1 | $119 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $90 |
| Novo Nordisk Inc | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Abbott Laboratories | 2 | $43 |
Products named: VYNDAQEL, AMVUTTRA, Kerendia, FUROSCIX, Attruby, LifeVest, Wegovy, LEQVIO.
Industry payments across AL — which companies pay providers there.
